Aquis AQSE - Delayed Quote GBp
Ananda Pharma Plc (ANA.AQ)
0.4000
0.0000
(0.00%)
As of April 24 at 4:38:32 PM GMT+1. Market Open.
Breakdown
TTM
1/31/2023
1/31/2022
1/31/2021
Operating Expense
1,667.6240
1,053.0420
970.0380
496.1100
Operating Income
-1,667.6240
-1,053.0420
-970.0380
-496.1100
Net Non Operating Interest Income Expense
-292.3950
-247.9830
--
0.1140
Pretax Income
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Net Income Common Stockholders
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Diluted NI Available to Com Stockholders
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Basic EPS
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
Basic Average Shares
2,873,847.4510
850,991.2710
721,530.9810
445,567.0520
Diluted Average Shares
2,873,847.4510
850,991.2710
721,530.9810
445,567.0520
Total Operating Income as Reported
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Total Expenses
1,667.6240
1,053.0420
970.0380
496.1100
Net Income from Continuing & Discontinued Operation
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Normalized Income
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Interest Income
--
--
--
0.1140
Interest Expense
--
247.9830
--
--
Net Interest Income
-292.3950
-247.9830
--
0.1140
EBIT
-1,667.6240
-1,053.0420
-970.0380
-496.1100
EBITDA
-1,667.6240
-880.7580
-970.0380
-496.1100
Reconciled Depreciation
--
172.2840
--
--
Net Income from Continuing Operation Net Minority Interest
-1,960.0190
-1,301.0250
-970.0380
-495.9960
Normalized EBITDA
-1,667.6240
-880.7580
-970.0380
-496.1100
1/31/2021 - 7/5/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade